Abbott Laboratories (XSWX:ABT) Interest Expense : CHF-484 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Abbott Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Abbott Laboratories's interest expense for the three months ended in Dec. 2023 was CHF -138 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-484 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Abbott Laboratories's Operating Income for the three months ended in Dec. 2023 was CHF 1,539 Mil. Abbott Laboratories's Interest Expense for the three months ended in Dec. 2023 was CHF -138 Mil. Abbott Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 was 11.19. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abbott Laboratories Interest Expense Historical Data

The historical data trend for Abbott Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Interest Expense Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-658.34

-485.07

-490.89

-519.83

-550.88

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-141.60	-143.16	-149.33	-137.50	-54.21

Abbott Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-484 Mil.

Abbott Laboratories (XSWX:ABT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abbott Laboratories's Interest Expense for the three months ended in Dec. 2023 was CHF-138 Mil. Its Operating Income for the three months ended in Dec. 2023 was CHF1,539 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was CHF12,581 Mil.

Abbott Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	1539.344	/	-137.503
	=	11.19

The higher the ratio, the stronger the company's financial strength is.

Abbott Laboratories (XSWX:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSWX:ABT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.